US4765980A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Stabilized porcine growth hormone
Assignee: International Minerals and Chemical Corp
•
Filing: 1986-04-28
•
Granted: 1988-08-23
•
Expires: 2006-04-28
Abstract
Abstract Porcine serum albumin stabilizes porcine growth hormone, and provided for sustained release of porcine growth hormone in implant devices for swine.
Inventors
- 👤 Randolph B. DePrince
- 👤 Ravi Viswanathan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 03:50
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61K38/00; A61K38/16; A61K38/17; A61K38/22; A61K38/27; A61K47/00; A61K47/30; A61K47/42
Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
27 words
A method for stabilizing porcine growth hormone comprising admixing porcine growth hormone or a physiologically acceptable metal complex thereof with a stabilizing amount of porcine serum albumin.
Claim 2
Independent Claim
27 words
A method for stabilizing porcine growth hormone comprising admixing porcine growth hormone or a physiologically acceptable metal complex thereof with a stabilizing amount of porcine serum albumin.
Claim 3
Dependent Claim
34 words
The method of claim 1 wherein said porcine serum albumin and porcine growth hormone or a physiologically acceptable metal complex thereof are admixed in a respective ratio of from about 10:1 to about 1:4.
Claim 4
Dependent Claim
11 words
The method of claim 2 wherein said ratio is about 4:1.
Claim 5
Dependent Claim
28 words
A stabilized porcine growth hormone composition comprising a mixture of porcine growth hormone or a physiologically acceptable metal complex thereof and a stabilizing amount of porcine serum albumin.
Claim 6
Dependent Claim
28 words
A stabilized porcine growth hormone composition comprising a mixture of porcine growth hormone or a physiologically acceptable metal complex thereof and a stabilizing amount of porcine serum albumin.
Claim 7
Dependent Claim
33 words
The composition of claim 4 having a respective ratio by weight of porcine serum albumin to porcine growth hormone or a physiologically acceptable metal complex thereof of from about 10:1 to about 1:4.
Claim 8
Dependent Claim
11 words
The composition of claim 5 wherein said ratio is about 4:1.
Claim 9
Dependent Claim
18 words
An implantable delivery device for sustained release of stabilized porcine growth hormone containing the composition of claim 4.
Claim 10
Dependent Claim
18 words
An implantable delivery device for sustained release of stabilized porcine growth hormone containing the composition of claim 5.
Claim 11
Dependent Claim
18 words
An implantable delivery device for sustained release of stabilized porcine growth hormone containing the composition of claim 6.
Claim 12
Dependent Claim
17 words
An implantable delivery device comprising a physiologically acceptable, implantable porous container containing the composition of claim 4.
Claim 13
Dependent Claim
17 words
An implantable delivery device comprising a physiologically acceptable, implantable porous container containing the composition of claim 5.
Claim 14
Dependent Claim
17 words
An implantable delivery device comprising a physiologically acceptable, implantable porous container containing the composition of claim 6.
Claim 15
Dependent Claim
13 words
The composition of claim 4 in the form of a substantially dry pellet.
Claim 16
Dependent Claim
13 words
The composition of claim 5 in the form of a substantially dry pellet.
Claim 17
Dependent Claim
13 words
The composition of claim 6 in the form of a substantially dry pellet.
Claim 18
Dependent Claim
17 words
A method for promoting the growth of swine comprising administering to swine the composition of claim 4.
Claim 19
Dependent Claim
17 words
A method for promoting the growth of swine comprising administering to swine the composition of claim 5.
Claim 20
Dependent Claim
17 words
A method for promoting the growth of swine comprising administering to swine the composition of claim 6.
Claim 21
Dependent Claim
18 words
The method of claim 16 wherein said composition is administered in the form of a sustained release implant.
Claim 22
Dependent Claim
18 words
The method of claim 17 wherein said composition is administered in the form of a sustained release implant.
Claim 23
Dependent Claim
18 words
The method of claim 18 wherein said composition is administered in the form of a sustained release implant.
References Cited (Backward Citations)
US1181424A
Cited
US2073354A
Cited
US2050558A
Cited
US2843525A
Cited
US2902408A
Cited
US3306823A
Cited
US3493652A
Cited
US3239418A
Cited
US3312594A
Cited
US3264186A
Cited
US3642003A
Cited
US3664925A
Cited
US3867520A
Cited
US4450150A
Cited
US4003846A
Cited
US4107288A
Cited
DE2603321A1
Cited
US4046871A
Cited
US4130554A
Cited
US4101649A
Cited
US4117118A
Cited
US4059694A
Cited
US4054558A
Cited
US4146611A
Cited
US4357259A
Cited
US4503035A
Cited
US4503035B1
Cited
US4427659A
Cited
US4452782A
Cited
US4390527A
Cited
US4371523A
Cited
US4439424A
Cited
US4411890A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-08-23 | 1992-02-22 | 1992-08-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-08-23 | 1996-02-22 | 1996-08-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-08-23 | 2000-02-22 | 2000-08-23 | $7700.00 | Window Closed / Lapsed |